BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3125865)

  • 21. Directional movement of cells in vivo and in vitro under the influence of 5-lipoxygenase inhibitors.
    Boot JR; Kitchen EA; Walker JR; Harvey J; Dawson W
    Br J Dermatol; 1985 Jul; 113 Suppl 28():168-76. PubMed ID: 3925978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of prostaglandins, prostaglandin metabolites and arachidonic acid to elicit chemotaxis of human polymorphonuclear leukocytes.
    Pazzaglia A; Barker A; Warin AP; Greaves MW
    Br J Dermatol; 1977 May; 96(5):533-6. PubMed ID: 871389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo evidence for the chemotactic activity of cyclooxygenase- and lipoxygenase-dependent compounds using a corneal implantation technique.
    Rochels R; Busse WD
    Ophthalmic Res; 1984; 16(4):194-7. PubMed ID: 6089067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human neutrophils by auranofin: chemotaxis and metabolism of arachidonate via the 5-lipoxygenase pathway.
    Elmgreen J; Ahnfelt-Rønne I; Nielsen OH
    Ann Rheum Dis; 1989 Feb; 48(2):134-8. PubMed ID: 2539060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelium-dependent contractions in rabbit pulmonary artery are mediated by thromboxane A2.
    Buzzard CJ; Pfister SL; Campbell WB
    Circ Res; 1993 May; 72(5):1023-34. PubMed ID: 8477518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil chemotaxis to leukotriene B4 in vitro is decreased for the human neonate.
    Dos Santos C; Davidson D
    Pediatr Res; 1993 Mar; 33(3):242-6. PubMed ID: 8384710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of arachidonic acid by canine polymorphonuclear leukocytes synthesis of lipoxygenase and omega-oxidized metabolites.
    Rosolowsky M; Falck JR; Campbell WB
    Biochim Biophys Acta; 1996 Apr; 1300(2):143-50. PubMed ID: 8652640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravascular chemoattractants inhibit diapedesis by selective receptor occupancy.
    Goldman G; Welbourn R; Klausner JM; Kobzik L; Valeri CR; Shepro D; Hechtman HB
    Am J Physiol; 1991 Feb; 260(2 Pt 2):H465-72. PubMed ID: 1847598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effect of indomethacin on polymorphonuclear leukocyte function in preterm infants.
    Kamran S; Usmani SS; Wapnir RA; Mehta R; Harper RG
    Pediatr Res; 1993 Jan; 33(1):32-5. PubMed ID: 8433857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of epoxyeicosatrienoic acids on polymorphonuclear leukocyte function.
    Pratt PF; Rosolowsky M; Campbell WB
    Life Sci; 2002 Apr; 70(21):2521-33. PubMed ID: 12173415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of leukocyte trafficking by lipoxins.
    Diamond P; McGinty A; Sugrue D; Brady HR; Godson C
    Clin Chem Lab Med; 1999 Mar; 37(3):293-7. PubMed ID: 10353475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of leukocyte-induced changes in endothelial barrier function.
    Gautam N; Hedqvist P; Lindbom L
    Br J Pharmacol; 1998 Nov; 125(5):1109-14. PubMed ID: 9846652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arachidonic acid metabolism in cultured astrocytes from rat embryo and in C6 glioma cells.
    Ishizaki Y; Morita I; Murota S
    Brain Res; 1989 Aug; 494(1):138-42. PubMed ID: 2504440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of arachidonic acid metabolites by endothelial cells in hyperoxia.
    Jackson RM; Chandler DB; Fulmer JD
    J Appl Physiol (1985); 1986 Aug; 61(2):584-91. PubMed ID: 3017913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pericardium as a source of prostacyclin in the dog, ox and rat.
    Nolan RD; Dusting GJ; Jakubowski J; Martin TJ
    Prostaglandins; 1982 Dec; 24(6):887-902. PubMed ID: 6820168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Injury to endothelial cells by phagocytosing polymorphonuclear leukocytes and modulatory role of lipoxygenase products.
    Vandenbroucke-Grauls CM; Thijssen HM; van Kessel KP; van Asbeck BS; Verhoef J
    Infect Immun; 1987 Jun; 55(6):1447-54. PubMed ID: 3106222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporation of platelet and leukocyte lipoxygenase metabolites by cultured vascular cells.
    Schafer AI; Takayama H; Farrell S; Gimbrone MA
    Blood; 1986 Feb; 67(2):373-8. PubMed ID: 3002525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukotriene D4 receptor-mediated synthesis and release of arachidonic acid metabolites in guinea pig lung: induction of thromboxane and prostacyclin biosynthesis by leukotriene D4.
    Mong S; Wu HL; Clark MA; Gleason JG; Crooke ST
    J Pharmacol Exp Ther; 1986 Oct; 239(1):63-70. PubMed ID: 3020235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bovine endothelial cells in culture produce thromboxane as well as prostacyclin.
    Ingerman-Wojenski C; Silver MJ; Smith JB; Macarak E
    J Clin Invest; 1981 May; 67(5):1292-6. PubMed ID: 7014633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.